Celosome Implant Filler with Hyaluronic Acid and Lidocaine, 1.1 ml

Available on backorder

Package: 1 syringe (1.1 ml) with needles, instruction leaflet, patient and doctor labels.
Lidocaine: included.
HA concentration: 24 mg/ml.
Volume: 1.1 ml.
Country of origin: South Korea.
Needles: 25G (2 per pack).

Price for cosmetologists

Main features

Description

Celosome Implant is the densest volumetric filler in the Celosome range, developed by the South Korean company ExoCoBio. It contains 24 mg/ml of cross-linked, non-animal hyaluronic acid and 0.3% lidocaine for comfortable injections.

Produced with the HENM cross-linking technology, it delivers results lasting 18–24 months while maintaining skin elasticity. An advanced 8-phase purification process minimizes risks of allergic reactions, swelling, and side effects.

The filler is injected subdermally or intradermally using various techniques (bolus, fanning, linear-retrograde) and is intended for significant correction.

Indications

  • treatment of deep wrinkles;

  • vector and lateral face lifting;

  • chin and cheek augmentation;

  • jawline contouring (“Jolie angles”);

  • restoring cheek volume.

Contraindications

Pregnancy, breastfeeding, diabetes, oncology, autoimmune disorders, skin conditions in the injection area, tendency to scarring, allergy to components, or presence of silicone gels in the correction zone.

Aftercare: avoid coffee, alcohol, smoking, salty or spicy food in the first days; refrain from tanning beds, sauna, pool, and intense workouts for two weeks.

Celosome Implant must be used exclusively by certified professionals in clinics or cosmetic salons.

Additional information
Brand (Fillers)

Celosome

Country (Fillers)

South Korea

Indications (Fillers)

,

,

,

,

,

,

Application Areas (Fillers)

,

,

Filler Base

Hyaluronic Acid Concentration

Density

Lidocaine

Duration of Action

Dermal Layers

Volume (ml) (Fillers)

1.1 ml

FAQ

Useful articles